Vnitr Lek 2018, 64(3):227-228 | DOI: 10.36290/vnl.2018.031

Choroby asociované s imunoglobulinem IgG4 - editorial

Jan Krejsek
Ústav klinické imunologie a alergologie LF UK a FN Hradec Králové

Received: September 11, 2017; Published: March 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejsek J. Choroby asociované s imunoglobulinem IgG4 - editorial. Vnitr Lek. 2018;64(3):227-228. doi: 10.36290/vnl.2018.031.
Download citation

References

  1. Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol 2017; 13(9): 867-875. Dostupné z DOI: <http://dx.doi.org/10.1080/1744666X.2017.1354698>. Go to original source... Go to PubMed...
  2. Frampton JE. Ocrelizumab: First global approval. Drugs 2017; 77(9): 1035-1041. Dostupné z DOI: <http://dx.doi.org/10.1007/s40265-017-0757-6>. Go to original source... Go to PubMed...
  3. Kawa S, Skold M, Ramsden DB et al. Serum IgG4 concentration in IgG4-related disease. Clin Lab 2017; 63(9): 1323-1337. Dostupné z DOI: <http://dx.doi.org/10.7754/Clin.Lab.2017.170403>. Go to original source... Go to PubMed...
  4. Trampert DC, Hubers LM, van de Graaf SFJ et al. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta 2017. pii: S0925-4439(17)30273-9. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bbadis.2017.07.038>. Go to original source... Go to PubMed...
  5. Yadlapati S, Verheyen E, Efthimiou P. IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 2018; 38(2): 169-177. Dostupné z DOI: <http://dx.doi.org/10.1007/s00296-017-3765-7>. Go to original source... Go to PubMed...
  6. Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. Garamon: Hradec Králové 2016. ISBN 978-80-86472-74-4.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.